Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion type Assertion NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_head.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion wasGeneratedBy ECO_0000203 NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_provenance.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion wasDerivedFrom befree-20140225 NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_provenance.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion SIO_000772 21607557 NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_provenance.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion evidence source_evidence_literature NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_provenance.
- NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_assertion description "[Gemcitabine (GEM), a standard therapeutic drug for PC, was examined for the regulation of WT1 expression and the sensitizing effect on PC cells with WT1-specific antitumor immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450866.RAS22-JKPpYca-BjFBo_MrU7JFVBYvl5TYTSRxRHpOS1M130_provenance.